California Bridge Access Program
No-cost COVID-19 vaccines for uninsured & underinsured adults
Alerts: |
---|
Vaccine Managment
Program Updates
Clinical Guidance
|
Program Overview
The HHS Bridge Access Program (BAP) for COVID-19 Vaccines and Treatments is a temporary measure connected to the commercialization of COVID-19 vaccines and treatment. It was created to prevent loss of access to free COVID-19 vaccines and treatment for uninsured and underinsured aged 19 years and older. The State program will utilize existing public health infrastructure, HRSA-supported health centers, and participating pharmacies (which will continue to offer free COVID-19 vaccinations and treatment).
The program will end on December 31, 2024. Refer to the CDC’s Bridge Access Program, and the CDPH BAP Requirements at a Glance for more information.
Program Resources
- Provider Participation Agreement
- Requirements at a Glance (includes guidance and job aids)
- Talking Points for BAP COVID-19 Vaccines and Treatment (NCIRD)
- Infographic – Where Can Someone Get Vaccine? (CDC)
- FAQs about the Bridge Access Program (CDC)
Program Enrollment
Local health departments, Federally Qualified Health Centers (FQHCs)/Rural Health Centers, tribal clinics, Indian Health Services sites, and additional providers deemed eligible by LHDs have been enrolled in the Bridge Access Program. Providers were asked to complete enrollment by October 27,2023. Interested and eligible providers who did not enroll by the deadline should reach out to their LHD and express interest in enrollment. Multi-County Entities (MCEs) and Correctional Facilities do not qualify.
Enrollment Resources
- Enrolling in the Bridge Access Program
- Enrolling in CAIR (required)
- Enrolling in My Turn (optional)
Vaccine Access, Products & Timing Guides
COVID-19 vaccines are now considered routine vaccines. Moderna, Novavax, and Pfizer-BioNTech adult vaccine products will be available through this program.
- Vaccine Ordering and Manufacturer Info (private and public vaccine)
- COVID Vaccine Product Guide
- COVID Timing Guide | Spanish
- Updated COVID-19 Vaccines for Use in the United States Beginning in Fall 2023 (FDA)
Required Training
All staff completing the BAP Provider Participation Agreement must complete the required program training in myCAvax before enrollment. Any staff who store, handle, or administer COVID-19 vaccines must also complete COVID-19 Vaccine Product Training prior to receiving vaccine shipments.
Providers administering the Novavax vaccine for the first time must also complete the updated Novavax product training.
Provider Operations
Additional Resources
- BAP Eligibility
- BAP Eligibility Screening, Vaccine Administration, and Vaccine Management
- COVID-19 Vaccine Resources: For Providers | For Patients